bh IN BRIEF   Employers are challenged by high-cost individual drug claims, especially by ‘new and improved’ (and costly) biologic products. Insurer claim pooling is inexpensive, but many employers don’t buy it, or believe it provides only limited protection after they incur a large claim. Ever-escalating claims are driving smaller employers to reduce or eliminate … Continue reading Testing the Waters – A National Pool for High-Cost Drug Claims